With five products on the market and a fully-integrated multinational organization in place, BioMarin is providing innovative therapeutics to patients with serious unmet medical needs.
- BioMarin Completes Rolling NDA Submission to FDA for Drisapersen for Treatment of Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping... MORE >
- BioMarin Presents Data on Duchenne Muscular Dystrophy at the 67th American Academy of Neurology Annual Meeting... MORE >
- BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)... MORE >
- /> Click here to learn more about VIMIZIM (elosulfase alfa), including full prescribing information and boxed warning.
- /> MorquioAnswers.com is an educational site for health care professionals to learn more about Morquio A diagnosis and management.
- Morquiosity.com is designed to empower the Morquio A community through education and support.
- PKU.com is a comprehensive online resource for the PKU community.